These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diabetic nephropathy: new approaches for improving glycemic control and reducing risk. Schernthaner G; Schernthaner GH J Nephrol; 2013; 26(6):975-85. PubMed ID: 23807645 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis, implication, prevention and treatment of microalbuminuria]. Bothe D Dtsch Med Wochenschr; 2012 Nov; 137(46):2390; author reply 2390-1. PubMed ID: 23132160 [No Abstract] [Full Text] [Related]
6. Diabetes: Glycemic and blood-pressure control--lower is not better. Ruilope LM Nat Rev Nephrol; 2012 Feb; 8(4):199-200. PubMed ID: 22330972 [No Abstract] [Full Text] [Related]
7. [Metformin is also recommended in mild and moderate renal failure]. Zechmann S Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780 [No Abstract] [Full Text] [Related]
8. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60? Bloomgarden Z Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220 [No Abstract] [Full Text] [Related]
9. [Diagnosis, implication, prevention and treatment of microalbuminuria]. Schmieder RE; Bramlage P Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183 [No Abstract] [Full Text] [Related]
11. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors. Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Heerspink HJ; van Raalte DH Lancet Diabetes Endocrinol; 2015 May; 3(5):367-81. PubMed ID: 25943756 [TBL] [Abstract][Full Text] [Related]
12. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update. Aperis G J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390 [No Abstract] [Full Text] [Related]
13. Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope? Ingelfinger JR; Rosen CJ N Engl J Med; 2016 Jul; 375(4):380-2. PubMed ID: 27331286 [No Abstract] [Full Text] [Related]
14. [New oral hypoglycemic drugs in diabetic kidney disease]. Dylewska M; Graczyk M Wiad Lek; 2017; 70(6 pt 2):1193-1196. PubMed ID: 29533912 [TBL] [Abstract][Full Text] [Related]
15. Unmet need in diabetic nephropathy: failed drugs or trials? de Zeeuw D; Heerspink HJL Lancet Diabetes Endocrinol; 2016 Aug; 4(8):638-640. PubMed ID: 27160545 [No Abstract] [Full Text] [Related]
16. Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney disease. Wanner C Nat Rev Nephrol; 2018 Feb; 14(2):78-80. PubMed ID: 29307892 [No Abstract] [Full Text] [Related]
17. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents. Fang V; Wazny LD; Raymond CB CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681 [No Abstract] [Full Text] [Related]
18. Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy. Tomino Y; Shirato I; Horikoshi S; Fukui M; Yamaguchi Y; Yokomatsu M; Ebihara I; Shimada N; Hishiki T; Hirano K; Rinno H; Shiota J; Kuramoto T Nephron; 2000 Jun; 85(2):190. PubMed ID: 10867532 [No Abstract] [Full Text] [Related]
19. Management of hyperglycemia in patients with chronic kidney disease. Aires Neto P; Gomes HV; Campos M J Nephrol; 2013; 26(4):629-35. PubMed ID: 23807643 [TBL] [Abstract][Full Text] [Related]
20. [Diabetic patient with liver or kidney disease. Which antidiabetics are allowed?]. Stiefelhagen P MMW Fortschr Med; 2010 Jun; 152(22):18. PubMed ID: 20590025 [No Abstract] [Full Text] [Related] [Next] [New Search]